• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特应性皮炎:其社会和经济成本。

Atopic eczema: its social and financial costs.

作者信息

Kemp A S

机构信息

Department of Immunology, Royal Children's Hospital, Parkville, Victoria, Australia.

出版信息

J Paediatr Child Health. 1999 Jun;35(3):229-31. doi: 10.1046/j.1440-1754.1999.00343.x.

DOI:10.1046/j.1440-1754.1999.00343.x
PMID:10404440
Abstract

Atopic dermatitis is a disorder with considerable social and financial costs. A recent Australian study indicates that the family stress related to the care of a child with moderate or severe atopic dermatitis is significantly greater than that of care of children with insulin-dependent diabetes mellitus. The factors contributing to family stress include: sleep deprivation; loss of employment; time taken for care of atopic dermatitis; and financial costs. An estimate of the yearly financial costs for a family and community (which includes medical, hospital, direct costs of treatments and indirect costs from loss of employment), range from $A1142 per child per year with mild atopic dermatitis, to $A6099 per year for a child with severe atopic dermatitis. As the current prevalence of atopic dermatitis in Australia is 10-15%, this indicates a considerable financial burden on the community. It is possible that appropriate interventions directed to reducing trigger factors, may produce worthwhile savings, in addition to benefits for the individuals and families. Atopic dermatitis should not be regarded as a minor skin disorder but as a condition which has the potential to be a major handicap involving considerable personal, social and financial consequences both for the family and for the community.

摘要

特应性皮炎是一种会带来相当大社会和经济成本的疾病。澳大利亚最近的一项研究表明,照顾患有中度或重度特应性皮炎儿童所产生的家庭压力,显著大于照顾患有胰岛素依赖型糖尿病儿童的家庭压力。导致家庭压力的因素包括:睡眠不足;失业;照顾特应性皮炎患儿所花费的时间;以及经济成本。据估计,一个家庭和社区每年的经济成本(包括医疗、住院、治疗的直接成本以及失业造成的间接成本),从轻度特应性皮炎患儿每年每人1142澳元,到重度特应性皮炎患儿每年每人6099澳元不等。由于目前澳大利亚特应性皮炎的患病率为10%-15%,这表明该病给社区带来了相当大的经济负担。除了对个人和家庭有益之外,针对减少触发因素的适当干预措施可能会带来可观的节省。特应性皮炎不应被视为一种轻微的皮肤疾病,而应被视为一种有可能成为重大障碍的疾病,会给家庭和社区带来相当大的个人、社会和经济后果。

相似文献

1
Atopic eczema: its social and financial costs.特应性皮炎:其社会和经济成本。
J Paediatr Child Health. 1999 Jun;35(3):229-31. doi: 10.1046/j.1440-1754.1999.00343.x.
2
Cost of illness of atopic dermatitis in children: a societal perspective.儿童特应性皮炎的疾病成本:社会视角
Pharmacoeconomics. 2003;21(2):105-13. doi: 10.2165/00019053-200321020-00003.
3
Atopic eczema: its impact on the family and financial cost.特应性皮炎:对家庭的影响及经济成本
Arch Dis Child. 1997 Feb;76(2):159-62. doi: 10.1136/adc.76.2.159.
4
The burden of atopic dermatitis: impact on the patient, family, and society.特应性皮炎的负担:对患者、家庭和社会的影响。
Pediatr Dermatol. 2005 May-Jun;22(3):192-9. doi: 10.1111/j.1525-1470.2005.22303.x.
5
The Financial and Emotional Impact of Atopic Dermatitis on Children and Their Families.特应性皮炎对儿童及其家庭的经济和情感影响。
J Pediatr. 2016 Feb;169:284-90.e5. doi: 10.1016/j.jpeds.2015.10.077. Epub 2015 Nov 23.
6
The Burden of Atopic Dermatitis: Summary of a Report for the National Eczema Association.特应性皮炎的负担:美国国家湿疹协会报告摘要
J Invest Dermatol. 2017 Jan;137(1):26-30. doi: 10.1016/j.jid.2016.07.012. Epub 2016 Sep 8.
7
Pharmacoeconomics of drug therapy for atopic dermatitis.特应性皮炎药物治疗的药物经济学
Expert Opin Pharmacother. 2002 Mar;3(3):249-55. doi: 10.1517/14656566.3.3.249.
8
Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema.生活质量与儿童特应性皮炎:儿童湿疹患者的痛苦生活
Int J Clin Pract. 2006 Aug;60(8):984-92. doi: 10.1111/j.1742-1241.2006.01047.x.
9
Public Health Burden and Epidemiology of Atopic Dermatitis.特应性皮炎的公共卫生负担与流行病学
Dermatol Clin. 2017 Jul;35(3):283-289. doi: 10.1016/j.det.2017.02.002. Epub 2017 Apr 22.
10
The costs of atopy and asthma in children: assessment of direct costs and their determinants in a birth cohort.儿童特应性疾病和哮喘的成本:对出生队列中直接成本及其决定因素的评估。
Pediatr Allergy Immunol. 2003 Feb;14(1):18-26. doi: 10.1034/j.1399-3038.2003.02085.x.

引用本文的文献

1
Prevalence trends and risk factors for allergic rhinoconjunctivitis, asthma and eczema in the UK.英国过敏性鼻结膜炎、哮喘和湿疹的患病率趋势及风险因素
Allergy Asthma Clin Immunol. 2025 Jul 7;21(1):31. doi: 10.1186/s13223-025-00975-2.
2
Burden of Disease and Unmet Needs in the Diagnosis and Management of Atopic Dermatitis in Diverse Skin Types in Australia.澳大利亚不同皮肤类型特应性皮炎诊断与管理中的疾病负担及未满足需求
J Clin Med. 2023 Jun 1;12(11):3812. doi: 10.3390/jcm12113812.
3
The global, regional, and national burden of atopic dermatitis in 195 countries and territories: An ecological study from the Global Burden of Disease Study 2017.
195个国家和地区特应性皮炎的全球、区域和国家负担:一项来自2017年全球疾病负担研究的生态学研究
JAAD Int. 2020 Nov 30;2:12-18. doi: 10.1016/j.jdin.2020.10.002. eCollection 2021 Mar.
4
Sleep Disturbances and Atopic Dermatitis: Relationships, Methods for Assessment, and Therapies.睡眠障碍与特应性皮炎:关系、评估方法和治疗。
J Allergy Clin Immunol Pract. 2021 Apr;9(4):1488-1500. doi: 10.1016/j.jaip.2020.12.007. Epub 2020 Dec 13.
5
Probiotics for treating eczema.用于治疗湿疹的益生菌。
Cochrane Database Syst Rev. 2018 Nov 21;11(11):CD006135. doi: 10.1002/14651858.CD006135.pub3.
6
Awareness of Atopic Dermatitis and Attitudes toward Different Types of Medical Institutions for Its Treatment among Adult Patients and the Parents of Pediatric Patients: A Survey of 500 Participants.成人患者及儿童患者家长对特应性皮炎的认知及其对不同类型医疗机构治疗特应性皮炎的态度:一项针对500名参与者的调查
Ann Dermatol. 2016 Dec;28(6):725-732. doi: 10.5021/ad.2016.28.6.725. Epub 2016 Nov 23.
7
Maternal prenatal and/or postnatal n-3 long chain polyunsaturated fatty acids (LCPUFA) supplementation for preventing allergies in early childhood.孕期及产后补充母体n-3长链多不饱和脂肪酸(LCPUFA)预防幼儿过敏
Cochrane Database Syst Rev. 2015 Jul 22;2015(7):CD010085. doi: 10.1002/14651858.CD010085.pub2.
8
Cumulative life damage in dermatology.皮肤病学中的累积性生命损害。
Dermatol Reports. 2011 Apr 12;3(1):e5. doi: 10.4081/dr.2011.e5. eCollection 2011 Jan 31.
9
Immunologic effects of omalizumab in children with severe refractory atopic dermatitis: a randomized, placebo-controlled clinical trial.奥马珠单抗治疗儿童重症难治性特应性皮炎的免疫效应:一项随机、安慰剂对照临床试验。
Int Arch Allergy Immunol. 2013;162(1):89-93. doi: 10.1159/000350486. Epub 2013 Jun 27.
10
Overview of Reviews The prevention of eczema in infants and children: an overview of Cochrane and non-Cochrane reviews.综述概述 婴幼儿湿疹的预防:Cochrane综述与非Cochrane综述概述
Evid Based Child Health. 2011 Sep;6(5):1322-1339. doi: 10.1002/ebch.827. Epub 2011 Sep 8.